Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2015 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2015 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis

  • Authors:
    • Yujie Li
    • Yan Guo
    • Ying Chen
    • Yajie Wang
    • Yun You
    • Qing Yang
    • Xiaogang Weng
    • Qi Li
    • Xiaoxin Zhu
    • Bingbing Zhou
    • Xucen Liu
    • Zaipeng Gong
    • Ruijie Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacokinetics of Chinese Materia Medica, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1665-1676
    |
    Published online on: April 23, 2015
       https://doi.org/10.3892/mmr.2015.3668
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Increasing evidence supports the hypothesis that inflammatory reactions serves an important function in the formation, progression and plaque rupture of atherosclerosis. Interleukin (IL)‑1 primarily induces inflammation and is closely associated with the inflammatory environment and the formation of atherosclerosis. The present study aimed to establish an in vitro model for the evaluation of drug efficacy in the intervention of atherosclerosis from the inflammatory perspective, and to observe the anti‑inflammatory effects of tanshinone IIA and andrographolide on atherosclerosis. The IL‑1β‑induced inflammation‑activated endothelial cell (EC)‑smooth muscle cell (SMC)‑mononuclear cell (MC) co‑culture model was established, based on the changes in a series of atherosclerosis‑associated inflammatory markers secreted by ECs and SMCs. The expression of connexin in ECs, adhesion of MCs and changes in inflammatory signalling molecules were selected as evaluation indices for the inflammatory microenvironment of atherosclerosis. The use of this model revealed that tanshinone IIA exhibited significant efficacy against atherosclerosis and its inflammatory reactions. Inflammatory reactions were regarded as the primary mechanism underlying atherosclerosis. The established model simulated a series of relevant changes in the arterial wall under the inflammatory cytokines with oxidized low‑density lipoprotein during the atherosclerotic process. The present study presented a reliable method for the identification of drugs with potential anti‑inflammatory activity in atherosclerosis, for investigating the mechanisms of action, considering the improvement of the inflammatory state and the increase in plaque stability observed.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Libby P: Inflammation in atherosclerosis. Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Wong BW, Meredith A, Lin D and McManus BM: The biological role of inflammation in atherosclerosis. Can J Cardiol. 28:631–641. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK and Jialal I: Inflammation, atherosclerosis and psoriasis. Clin Rev Allergy Immunol. 44:194–204. 2013. View Article : Google Scholar

4 

Charo IF and Taub R: Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov. 10:365–376. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Ridker PM, Thuren T, Zalewski A and Libby P: Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Am Heart J. 162:597–605. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Ridker PM: Testing the inflammatory hypothesis of athero-thrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J Thromb Haemost. 7:332–339. 2009. View Article : Google Scholar

7 

Verma S, Gupta M and Ridker PM: Therapeutic targeting of inflammation in atherosclerosis: we are getting closer. Can J Cardiol. 28:619–622. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Libby P: Inflammation in atherosclerosis. Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Davies PF: Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest. 55:5–24. 1986.PubMed/NCBI

10 

Campbell JH and Campbell GR: Endothelial cell influences on vascular smooth muscle phenotype. Annu Rev Physiol. 48:295–306. 1986. View Article : Google Scholar : PubMed/NCBI

11 

Powell RJ, Hydowski J, Frank O, Bhargava J and Sumpio BE: Endothelial cell effect on smooth muscle cell collagen synthesis. J Surg Res. 69:113–118. 1997. View Article : Google Scholar : PubMed/NCBI

12 

Powell RJ, Bhargava J, Basson MD and Sumpio BE: Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. Am J Physiol. 274:H642–H649. 1998.PubMed/NCBI

13 

Lyle AN and Griendling KK: Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda). 21:269–280. 2006. View Article : Google Scholar

14 

Spagnoli LG, Villaschi S, Neri L and Palmieri G: Gap junctions in myo-endothelial bridges of rabbit carotid arteries. Experientia. 38:124–125. 1982. View Article : Google Scholar : PubMed/NCBI

15 

Fillinger MF, O’Connor SE, Wagner RJ and Cronenwett JL: The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg. 17:1058–1067; discussion 1067–1068. 1993. View Article : Google Scholar : PubMed/NCBI

16 

Powell RJ, Carruth JA, Basson MD, Bloodgood R and Sumpio BE: Matrix-specific effect of endothelial control of smooth muscle cell migration. J Vasc Surg. 24:51–57. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Kinard F, Jaworski K, Sergent-Engelen T, et al: Smooth muscle cells influence monocyte response to LDL as well as their adhesion and transmigration in a coculture model of the arterial wall. J Vasc Res. 38:479–491. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Dorweiler B, Torzewski M, Dahm M, et al: A novel in vitro model for the study of plaque development in atherosclerosis. Thromb Haemost. 95:182–189. 2006.PubMed/NCBI

19 

Nam MH, Lee HS, Seomun Y, Lee Y and Lee KW: Monocyte-endothelium-smooth muscle cell interaction in co-culture: proliferation and cytokine productions in response to advanced glycation end products. Biochim Biophys Acta. 1810:907–912. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Desai A, Darland G, Bland JS, Tripp Ml and Konda VR: META060 attenuates TNF-alpha-activated inf lam-mation, endothelial-monocyte interactions and matrix metalloproteinase-9 expression and inhibits NF-kappaB and AP-1 in THP-1 monocytes. Atherosclerosis. 223:130–136. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Moon MK, Lee YJ, Kim JS, Kang DG and Lee HS: Effect of caffeic acid on tumour necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull. 32:1371–1377. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Deuell KA, Callegari A, Giachelli CM, Rosenfeld ME and Scatena M: RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-alpha. J Vasc Res. 49:510–521. 2012. View Article : Google Scholar

23 

Hoge M and Amar S: Role of interleukin-1 in bacterial athero-genesis. Drugs Today (Barc). 42:683–688. 2006. View Article : Google Scholar

24 

Bhaskar V, Yin J, Mirza AM, et al: Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice. Atherosclerosis. 216:313–320. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Chamberlain J, Francis S, Brookes Z, et al: Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS One. 4:e50732009. View Article : Google Scholar : PubMed/NCBI

26 

Jiang Y, Wang M, Huang K, et al: Oxidized low-density lipo-protein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. Biochem Biophys Res Commun. 425:121–126. 2012. View Article : Google Scholar : PubMed/NCBI

27 

Sivapalaratnam S, Farrugia R, Nieuwdorp M, et al: Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study. BMC Med Genomics. 4:642011. View Article : Google Scholar : PubMed/NCBI

28 

Navab M, Hough GP, Stevenson LW, Drinkwater DC, Laks H and Fogelman AM: Monocyte migration into the subendo-thelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 82:1853–1863. 1988. View Article : Google Scholar : PubMed/NCBI

29 

Van Lenten BJ, Hama SY, de Beer FC, et al: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 96:2758–2767. 1995. View Article : Google Scholar : PubMed/NCBI

30 

Ishikawa K, Navab M, Leitinger N, Fogelman AM and Lusis AJ: Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 100:1209–1216. 1997. View Article : Google Scholar : PubMed/NCBI

31 

Takaku M, Wada Y, Jinnouchi K, et al: An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler Thromb Vasc Biol. 19:2330–2339. 1999. View Article : Google Scholar : PubMed/NCBI

32 

Zhang JC, Ruan Q, Paucz L, Fabry A, Binder BR and Wojta J: Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro. J Vasc Res. 36:126–132. 1999. View Article : Google Scholar : PubMed/NCBI

33 

Rainger GE, Stone P, Morland CM and Nash GB: A novel system for investigating the ability of smooth muscle cells and fibroblasts to regulate adhesion of flowing leukocytes to endothelial cells. J Immunol Methods. 255:73–82. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Chao CY, Lii CK, Tsai IT, Li CC, Liu KL, Tsai CW and Chen HW: Andrographolide inhibits ICAM-1 expression and NF-κB activation in TNF-α-treated EA.hy926 cells. J Agric Food Chem. 59:5263–5271. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Wang YH, Yan ZQ, Qi YX, et al: Normal shear stress and vascular smooth muscle cells modulate migration of endothelial cells through histone deacetylase 6 activation and tubulin acetylation. Ann Biomed Eng. 38:729–737. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Evensen L, Micklem DR, Blois A, et al: Mural cell associated VEGF is required for organotypic vessel formation. PLoS One. 4:e57982009. View Article : Google Scholar : PubMed/NCBI

37 

Wang YH, Yan ZQ, Shen BR, Zhang L, Zhang P and Jiang ZL: Vascular smooth muscle cells promote endothelial cell adhesion via microtubule dynamics and activation of paxillin and the extracellular signal-regulated kinase (ERK) pathway in a co-culture system. Eur J Cell Biol. 88:701–709. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Ruan LM, Cai W, Chen JZ and Duan JF: Effects of losartan on expression of connexins at the early stage of atherosclerosis in rabbits. Int J Med Sci. 7:82–89. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Larson DM, Haudenschild CC and Beyer EC: Gap junction messenger RNA expression by vascular wall cells. Circ Res. 66:1074–1080. 1990. View Article : Google Scholar : PubMed/NCBI

40 

Navab M, Liao F, Hough GP, et al: Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. J Clin Invest. 87:1763–1772. 1991. View Article : Google Scholar : PubMed/NCBI

41 

Leclercq A, Houard X, Loyau S, et al: Topology of protease activities reflects atherothrombotic plaque complexity. Atherosclerosis. 191:1–10. 2007. View Article : Google Scholar

42 

Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S and Iguchi A: Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 26:1120–1125. 2006. View Article : Google Scholar : PubMed/NCBI

43 

Lin R, Wang WR, Liu JT, Yang GD and Han CJ: Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J Ethnopharmacol. 108:217–222. 2006. View Article : Google Scholar : PubMed/NCBI

44 

Zhang WL, Xiao Y, Liu JP, et al: Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model. Int J Pharm. 419:314–321. 2011. View Article : Google Scholar : PubMed/NCBI

45 

Liu Z, Wang J, Huang E, et al: Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of haem oxygenase-1. J Lipid Res. 55:201–213. 2014. View Article : Google Scholar :

46 

Stumpf C, Fan Q, Hintermann C, et al: Anti-inflammatory effects of danshen on human vascular endothelial cells in culture. Am J Chin Med. 41:1065–1077. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Lee KC, Chang HH, Chung YH and Lee TY: Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-kappaB pathway. J Ethnopharmacol. 135:678–684. 2011. View Article : Google Scholar : PubMed/NCBI

48 

Guo W, Liu W, Chen G, et al: Water-soluble androgra-pholide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-κB pathways. Int Immunopharmacol. 14:613–619. 2012. View Article : Google Scholar : PubMed/NCBI

49 

Fang ZY, Lin R, Yuan BX, Yang GD, Liu Y and Zhang H: Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J Ethnopharmacol. 115:217–222. 2008. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang Q, Weng X, Li Q, Zhu X, Zhou B, Zhou B, et al: Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep 12: 1665-1676, 2015.
APA
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q. ... Zhang, R. (2015). Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis. Molecular Medicine Reports, 12, 1665-1676. https://doi.org/10.3892/mmr.2015.3668
MLA
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q., Weng, X., Li, Q., Zhu, X., Zhou, B., Liu, X., Gong, Z., Zhang, R."Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis". Molecular Medicine Reports 12.2 (2015): 1665-1676.
Chicago
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q., Weng, X., Li, Q., Zhu, X., Zhou, B., Liu, X., Gong, Z., Zhang, R."Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis". Molecular Medicine Reports 12, no. 2 (2015): 1665-1676. https://doi.org/10.3892/mmr.2015.3668
Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang Q, Weng X, Li Q, Zhu X, Zhou B, Zhou B, et al: Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep 12: 1665-1676, 2015.
APA
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q. ... Zhang, R. (2015). Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis. Molecular Medicine Reports, 12, 1665-1676. https://doi.org/10.3892/mmr.2015.3668
MLA
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q., Weng, X., Li, Q., Zhu, X., Zhou, B., Liu, X., Gong, Z., Zhang, R."Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis". Molecular Medicine Reports 12.2 (2015): 1665-1676.
Chicago
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q., Weng, X., Li, Q., Zhu, X., Zhou, B., Liu, X., Gong, Z., Zhang, R."Establishment of an interleukin‑1β‑induced inflammation‑activated endothelial cell‑smooth muscle cell‑mononuclear cell co‑culture model and evaluation of the anti‑inflammatory effects of tanshinone IIA on atherosclerosis". Molecular Medicine Reports 12, no. 2 (2015): 1665-1676. https://doi.org/10.3892/mmr.2015.3668
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team